| Michael Edward Critchlow, M D | |
|
1012 N Main St, Sikeston, MO 63801-5044 | |
| (573) 471-0330 | |
| (573) 472-2966 |
| Full Name | Michael Edward Critchlow |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1012 N Main St, Sikeston, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720079841 | NPI | - | NPPES |
| 200384220 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 25720 (Missouri) | Secondary |
| 207R00000X | Internal Medicine | R8486 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Edward Critchlow, M D 1012 N Main St, Sikeston, MO 63801-5044 Ph: (573) 471-0330 | Michael Edward Critchlow, M D 1012 N Main St, Sikeston, MO 63801-5044 Ph: (573) 471-0330 |
News Archive
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
The researchers from Bristol University believe their discovery has major implications not just for wound victims, but also for people who suffer organ tissue damage through illness or abdominal surgery.
A group of health care and policy experts from the Perelman School of Medicine at the University of Pennsylvania is urging health care institutions to look more to their own in-house personnel, including physicians and nurses, as a source of new ideas for improving how care is delivered.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.
› Verified 8 days ago
Husam H Najjar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1019 N Main St, Sikeston, MO 63801 Phone: 573-472-7702 Fax: 573-472-7719 | |
Muhannad Al-kilani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1118 N Main St, Sikeston, MO 63801 Phone: 573-471-4417 Fax: 573-471-9010 | |
Syed K Hashmi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1008 N Main St, Sikeston, MO 63801 Phone: 573-472-6001 Fax: 573-472-6006 | |
Dr. Michael P. Chouinard, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1012 N Main St, Sikeston, MO 63801 Phone: 573-431-0330 Fax: 573-472-2966 | |
Abdel-qader Al-bashabsheh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1008 N Main St, Sikeston, MO 63801 Phone: 573-472-7565 Fax: 573-472-6015 | |
Dr. William C. Shell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1012 N Main St, Sikeston, MO 63801 Phone: 573-431-0330 Fax: 573-472-2966 | |
Justin Heath Bain, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1012 N Main St, Sikeston, MO 63801 Phone: 573-471-0330 Fax: 573-471-0461 |